Global Migraine Drugs Market 2016-2020
- Published: May 2016
- Pages: 63
- SKU: IRTNTR9324
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
This market research report presents a detailed segmentation of the global migraine drugs market by treatment type (preventive and abortive), by therapeutic class (triptans, ergots, and others), and by geography (the Americas, APAC, and EMEA). The leading vendors in the market are Allergan, Endo, GlaxoSmithKline, Impax Laboratories, and Pfizer.
Overview of the global migraine drugs market
According to the migraine drugs industry anlaysis, Technavio’s market research analysts estimate this market to grow at a CAGR of more than 4% between 2016 and 2020. One of the primary drivers for this market is the growing awareness about migraine and its treatment options. Several organizations such as the American Headache and Migraine Association are coming up with awareness programs and are providing assistance to patients in order to spread awareness about the disease and other headache-related disorders. Owing to the growing incidence of migraine and the presence of high unmet needs in this market, several companies have started investing in the R&D of migraine drugs, which in turn will boost the growth prospects for this market during the forecast period.
The increasing need for new treatment options has led to the development of new devices such as antimigraine devices and headbands in the market. For instance, Cefaly Transcutaneous Electrical Nerve Stimulation device is an FDA approved device for migraine treatment. This device stimulates the trigeminal nerve by emitting electric currents and provides remission from migraine. According to the migraine drugs industry insights, increasing spending on new research activities and novel product innovations will accelerate the growth and development of this market over the next four years.
Segmentation by therapeutic class and analysis of the migraine drugs market
- Triptans
- Ergots
Based on the migraine drugs market outlook, Triptans are the largest segment of the global migraine drugs market, occupying around 84% of the total market share in 2015. Some of the available drugs in this segment include Almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, and zolmitriptan. These medicines are formulated in various forms such as tablets, injections, and nasal spray preparations. The growing utilization of the oral route of administration (ROA) will augment the growth prospects for this segment in the coming years.
Geographical segmentation and analysis of the migraine drugs market
- Americas
- APAC
- EMEA
APAC will be the fastest-growing region in the migraine drugs market and is expected to grow at a CAGR of 6% by 2020. The primary reason for this reason’s growth is the increase in the number of people suffering from migraine and growing public awareness about the disease. India and China are the major markets in this region as the prevalence of migraine are high in these countries. The growing focus on new product launches and the high penetration of drug manufacturers will aid in the growth of the market in APAC during the forecast period.
Competitive landscape and key vendors
At present, the market is growing at a slow pace because of the increased genericization of drugs. The market is also witnessing high unmet needs as there is no permanent cure for the disease. This has propelled vendors in the market to make huge investments in R&D. Several companies are expected to enter the market during the predicted period. Companies that manufacture and sell migraine drugs that exhibit a high safety and efficacy profile are expected to gain a competitive edge over their peers.
Key vendors in the market are
- Allergan
- Endo
- GlaxoSmithKline
- Impax Laboratories
- Pfizer
The other prominent vendors in the migraine drugs market include Abbott, Aegis Therapeutics, Aeriel BioPharma, Alder Biopharmaceuticals, Allergan, Amgen, Astellas, AstraZeneca, Bayer, CoLucid, Dr. Reddy's Laboratories, Eisai, Eli Lilly, Ethypharm, IntelGenx, Johnson & Johnson, Klaria, Kowa Pharmaceuticals America, Luitpold Pharmaceuticals, Meda, Merck, OptiNose, Pfizer, Pozen, Raptor, RedHill, SUDA, Teva, TG Therapeutics, NValeant, Winston Pharmaceuticals, and Zogenix.
Key questions answered in the report include
- What will the migraine drugs market size and the growth rate be in 2020?
- What are the key factors driving the global migraine drugs market?
- What are the key migraine drugs market trends impacting the growth of the market?
- What are the challenges to market growth?
- Who are the key vendors in the global migraine drugs market?
- What are the market opportunities and threats faced by the vendors in the global migraine drugs market?
- Trending factors influencing the market shares of the Americas, APAC, and EMEA.
- What are the key outcomes of the five forces analysis of the global migraine drugs market?
Technavio also offers customization on reports based on specific client requirement.
Related reports
Table of Contents
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: Disease overview
- Types
- Cause
- Management
- Epidemiology
- Economic burden
- PART 06: Pipeline analysis
- Semprana
- Rizaport
- Sumatriptan
- DFN-11
- Lasmiditan
- SUD001
- AMG 334
- DFN-02
PART 07: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 08: Market segmentation by type of treatment
- Preventative
- Abortive
PART 09: Market segmentation by therapeutic class
- Triptans
- Ergot alkaloids
- Other
PART 10: Geographical segmentation
- Global migraine drugs market by geographical segmentation 2015-2020
- Migraine drugs market in Americas
- Migraine drugs market in EMEA
- Migraine drugs market in APAC
PART 11: Market drivers
- Growing awareness about migraine and its treatment options
- Tentative approval of pipeline candidates
- High unmet needs
- Increased prevalence of migraines
PART 12: Impact of drivers
PART 13: Market challenges
- Lack of proper diagnosis
- Adverse effects of drugs
- Increased preference for alternative therapies
- Generic penetration
PART 14: Impact of drivers and challenges
PART 15: Market trends
- Antimigraine devices and headbands
- Increase in R&D
- Novel product innovations
- Strategic alliances
PART 16: Vendor landscape
- Competitive scenario
- Allergan
- Endo International
- GlaxoSmithKline
- Impax
- Pfizer
- Other prominent vendors
PART 17: Appendix
- List of abbreviations
PART 18: Explore Technavio
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
